Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD

Status unconfirmed · Phase 2

Conditions studied: Brain Injuries, Traumatic, Neurocognitive Disorders, Brain Injuries

In brief

The experimental design is an open-label two-week trial of tolcapone to evaluate which clinical domains are affected by tolcapone treatment and to identify "responders" to tolcapone treatment in the two subject groups (BI and NCD)

Key facts

Study ID
NCT02652598
Run by
Sheppard Pratt Health System
People needed
100
Starts
2015-11-01
Last updated by the study team
2017-01-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.